Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-09

FDA Approved: INDOMETHACIN — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' supplemental application for Indomethacin, resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INDOMETHACIN (INDOMETHACIN)

Snippet

SUPPL AP for INDOMETHACIN (INDOMETHACIN)